• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of Pediatric Gastroenterology and Nutrition

    Journal of Pediatric Gastroenterology and Nutrition

    JournalISSN 0277-2116eISSN 1536-4801中科院 医学 3区

    年发文量

    研究主题

    论文(20005)

    排序
    1Pediatric Inflammatory Bowel Diseases in Patients with Genetic Syndromes: A Case–control Multicentre SIGENP Study
    Francesca Di Sario,Chiara Monachesi,Enrico Felici,Sara Curto,Flavio Labriola,Licia Pensabene,Serena Arrigo,Chiara Longo,Francesca Penagini,Giovanna Zuin, Giacomo Colella,Massimo Martinelli,

    Abstract Objectives To characterize the clinical phenotype and long‐term outcomes of pediatric inflammatory bowel disease (IBD) in patients with genetic syndromes. Methods Multicenter observational case‐control study using data from the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition IBD registry. Patients diagnosed with pediatric‐onset IBD (<18 years) between 2009 and 2024 were included. Syndromic cases were matched 1:2 with non‐syndromic controls by gender, age at diagnosis, IBD type, and follow‐up duration. Demographic, clinical, and therapeutic data were analyzed. Results Sixty‐nine patients were included (23 syndromic and 46 controls). At diagnosis, syndromic patients had lower weight (−1.16 z‐score, p = 0.004) and height (−1.43 z ‐score, p < 0.001); these differences persisted at follow‐up. Diagnostic delay was longer in syndromic patients (+6.5 months, p = 0.045). Abdominal pain was less frequent at presentation ( p = 0.01). Syndromic patients had more hospitalizations (IBD‐related incidence rate ratio [IRR] 1.23, p = 0.033; non‐IBD IRR 1.65, p < 0.001), more comorbidities (odds ratio [OR] 18.2, p < 0.001), and greater use of non‐IBD medications (OR 8.17, p = 0.004). The risk of additional autoimmune diseases was higher but not statistically significant. Conclusions Pediatric IBD patients with genetic syndromes show impaired growth and delayed diagnosis, while intestinal disease activity and treatment exposure are comparable to non‐syndromic peers. The higher burden of comorbidities and hospitalizations indicates greater healthcare complexity and diagnostic challenges; early recognition and coordinated multidisciplinary care are reasonable clinical considerations, but their impact on outcomes requires prospective evaluation.

    2026
    引用
    AI阅读
    加入学术空间
    2Looking below the Surface with Endoscopic Ultrasound.
    Sabina Mir, Garrett J. Sprague
    2026
    引用
    AI阅读
    加入学术空间
    3PD‐1/PD‐L1 Expression in Pediatric Duodenal Biopsies: Association with Mucosal Activity and Diagnostic Performance in Celiac Disease
    Gül Çirkin,Fatih Yılmaz

    Abstract Objectives The role of immune checkpoint molecules (ICMs) in celiac disease (CD) remains incompletely understood despite their expected function in limiting mucosal immune–mediated injury. This study aimed to evaluate duodenal PD‐1 and PD‐L1 expression in pediatric duodenal samples, investigate associations with histologic/serologic activity, and assess their diagnostic performance. Methods Patients' files who applied to the pediatric gastroenterology clinic and underwent esophagogastroduodenoscopy between 01.01.2022 and 31.12.2023 were retrospectively reviewed. CD was defined by European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)‐based clinicopathologic correlation. PD‐1/PD‐L1 immunohistochemistry was quantified as the number of positive mononuclear cells per HPF (40x) in the lamina propria in hot spot areas. The diagnostic potential in differentiating CD and non‐CD cases was investigated with receiver operating characteristics (ROC) analysis. Results A total of 142 children (mean age 10.3 ± 4.4 years; 64.8% male); 68 (47.9%) had CD, and 74 (52.1%) served as non‐CD controls. Both markers were significantly elevated in CD tissues ( p < 0.001). In ROC analysis, PD‐L1 outperformed PD‐1 for identifying CD (area under the curve: 0.933 vs. 0.809). A PD‐L1 > 6.5/HPF cut‐off yielded 92.6% sensitivity and 83.8% specificity. PD‐L1 was associated with an increase in Marsh grade in CD samples ( p = 0.033) and with an increase in IEL in non‐CD cases ( p = 0.016). Conclusion PD‐1 and PD‐L1 are specifically increased in CD, and PD‐L1 could be a candidate diagnostic marker for CD. In autoimmune disorders such as CD, elucidating the interactions, functional capacities, and degrees of involvement of these molecules can provide insights into the pathogenesis, diagnosis, and treatment.

    2026
    引用
    AI阅读
    加入学术空间
    4Pancreatic Involvement in Children with Newly Diagnosed Inflammatory Bowel Disease
    Jan Stanisław Bukowski, Mateusz Jermakow, Julia Iwoła‐Grabysz, Kinga Kamińska,Przemysław Bombiński,Aleksandra Banaszkiewicz

    OBJECTIVES: Pancreatic involvement in inflammatory bowel disease (IBD) represents a heterogeneous group of conditions. Our study assessed the prevalence of hyperlipasemia and pancreatic imaging involvement in children with newly diagnosed IBD. We also evaluated predictors of pancreatic changes on magnetic resonance imaging in this population. METHODS: This retrospective study analysed the standard magnetic resonance enterography (MRE) protocol with additional sequences for pancreatic assessment. The serum activity of lipase, aminotransferases, and total immunoglobulin G (IgG) and its subclasses concentrations were measured at diagnosis, as well as body mass index percentile (pBMI) and IBD activity. RESULTS: Data from 68 children were analysed. Increased IgG concentrations were observed in 25 patients (36.6%) for total IgG and in 25 patients (36.6%) for IgG1. Among 27 patients (39.7%) with increased lipase, 8 (29.6%) had increased IgG concentration and 10 (37.1%) had increased IgG1 concentration; both IgG and IgG1 concentration were elevated in 7 (87.5%) patients. MRE revealed pancreatic involvement in 20.59%. Patients with pancreatic involvement on MRE had higher total IgG (p = 0.012) and IgG1 (p = 0.024) levels and lipase activity 3x higher than the normal limit (p = 0.04). Total IgG and IgG1 concentrations were significantly associated with MRE findings and their combination yielded the highest discriminatory performance. IgG subclasses proved to be useful in a multivariate model incorporating IgG1 and IgG2 concentrations (0.75; 95% confidence interval: 0.59-0.92). CONCLUSION: Structural pancreatic involvement was observed in one-fifth of our patients. They had significantly higher total IgG and IgG1 levels. The IgG1 + IgG2 model performed best in prediction pancreatic MRE changes.

    2026
    引用
    AI阅读
    加入学术空间
    5Long‐term Follow‐up after Transfer of Care to Adult Healthcare in Paediatric Liver Transplant Recipients
    Alberto Ferrarese,Mara Cananzi,Giacomo Germani,Annalisa Dolcet,Umberto Cillo,Claudia Mescoli, Eleonora Munaretto,Francesco Paolo Russo,Marco Senzolo,Patrizia Burra

    OBJECTIVES: Paediatric liver transplantation (pLT) is associated with excellent long-term survival and quality of life. As a growing proportion of recipients survive into adulthood, long-term follow-up after transfer from paediatric to adult care is increasingly important. We aimed to describe patient and graft survival, retention in care, adherence, medical complications and achievement of an ideal outcome after transfer of care. METHODS: This prospective observational study included all pLT recipients who entered our centre's transition programme between January 2010 and December 2024. Prespecified outcomes included patient and graft survival, retention in adult care, attendance and medication adherence, a composite non-adherence outcome, post-transfer medical complications and the proportion achieving an ideal outcome at predefined timepoints. RESULTS: Sixty patients were included (53.3% male; median age at pLT 5 [2.1-10.4] years; median age at transfer of care 19.8 [interquartile range (IQR) 18.9-24] years). Patient survival at 1, 5, 10 and 15 years after transfer of care was 98%, 96%, 93% and 93%, while graft survival was 98%, 94%, 91% and 75%, respectively. At the time of transfer of care, 55% of patients fulfilled criteria for an ideal outcome; this decreased to 41.6% at 5 years and 25% at 10 years. Medication non-adherence was documented in 20%, and composite non-adherence in 25%. The tacrolimus Medication Level Variability Index was significantly associated with composite non-adherence (p = 0.007) and was higher in patients who developed chronic rejection than in those who did not (p = 0.05). CONCLUSIONS: Despite excellent long-term survival, pLT recipients reaching adulthood face increasing challenges over time, particularly regarding adherence. These descriptive findings support continued, individualised follow-up after transfer to adult healthcare.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 20005 篇论文

    高被引作者

    作者引用发文
    Hania Szajewska12786105
    Berthold Koletzko11478172
    Yvan Vandenplas11291179
    Raanan Shamir10684124
    Sibylle Koletzko1005784
    Sanja Kolacek880669
    Johannes B van Goudoever840160
    Christian Braegger751568
    D Turck731591
    Annamaria Staiano725380

    高产作者

    作者引用发文
    Riccardo Troncone3709216
    Marc A. Benninga6341194
    Yvan Vandenplas11291179
    Berthold Koletzko11478172
    Giorgina Mieli-Vergani2277133
    Raanan Shamir10684124
    Salvatore Cucchiara4758122
    Frederic Gottrand5184110
    Anne Griffiths6019107
    Hania Szajewska12786105

    相关期刊

    Archivos argentinos de pediatria
    Alimentary Pharmacology and Therapeutics
    Global Pediatric Health
    Nutrition In Clinical Practice
    World journal of clinical pediatrics
    Pediatrics International
    Archives de Pediatrie
    Pediatrics in Review
    Pediatric Gastroenterology, Hepatology & Nutrition
    Clinical and Experimental Pediatrics